Moreover, in human prostate cancer tissue sections and microarrays, CaSR expression was reported in both normal prostate and in primary prostate cancer samples as assessed by immunohistochemistry—but metastatic prostate cancer tissue obtained from bone had higher CaSR expression than primary prostate cancer tissue (Feng et al., 2014). This evidence concerns the gene CASR and prostate carcinoma.